Johns Hopkins receives the first NIH grant for clinical psychedelic research in half a century

Free Think

The National Institutes of Health (NIH) has awarded a roughly $4 million dollar research grant to Johns Hopkins to study the potential therapeutic effects of psilocybin on tobacco addiction.

According to the university, Hopkins’ grant is the first federal grant given in over 50 years for directly exploring the use of a classic psychedelic for therapeutic purposes. 

“The historical importance of this grant is monumental,” principal investigator Matthew Johnson said. 

Read more…